Skip to main content
. 2023 Jan 4;13:1070660. doi: 10.3389/fimmu.2022.1070660

Figure 5.

Figure 5

Subgroup analysis of the pooled CR. (A). Subgroup of CLL/SLL, the pooled CR of CLL/SLL with TP53 mutation/17p−deletion and others. (B). Subgroup of iNHL, the pooled CR of Follicular lymphoma (FL) and others. (C). Subgroup of aNHL, the pooled CR of MCL and others. (D). Subgroup of T-NHL, the pooled CR of PTCL and CTCL.